|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Non-controlling interest | |||||
| Bad debt | |||||
| Stock-based compensation | |||||
| Common stock issued for professional and marketing services | |||||
| Amortization of right of use assets | |||||
| Change in fair value of contingent consideration | |||||
| Depreciation | |||||
| Amortization of intangibles | |||||
| Deferred tax adjustments | |||||
| Excess value of common stock issued to settle liabilities | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Prepaid expenses and other current assets | |||||
| Other receivable, related party | |||||
| Due to / from related party | |||||
| Accounts payable | |||||
| Accounts payable, related party | |||||
| Accrued expenses and other current liabilities | |||||
| Contract liabilities | |||||
| Deferred tax liability | |||||
| Operating lease liabilities, net | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Cash and restricted cash acquired from business combinations | |||||
| Purchase of property, plant and equipment | |||||
| Software development capitalization | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Short-term advances, related party | |||||
| Proceeds from related party advances | |||||
| Proceeds from sale of common stock | |||||
| Repayment of loan | |||||
| Accounts receivable financing facility | |||||
| Proceeds from sale of common and preferred stock | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents and restricted cash at beginning of year | |||||
| Cash and cash equivalents and restricted cash at end of year | |||||
| Cash at beginning of year | |||||
| Restricted cash at beginning of year | |||||
| Cash and restricted cash at beginning of year | |||||
| Cash at end of year | |||||
| Restricted cash at end of year | |||||
| Cash and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Exchange of related party advances and accruals for a convertible note payable and subsequent conversion into common stock | |||||
| Common stock issued for assets | |||||
| Settlement of a liability by a shareholder | |||||
| Cash paid for interest | |||||
| Issuances of common stock for consulting and marketing services - prepaid expense | |||||
| Supplemental disclosure of non-cash investing and financing activities | |||||
| Purchase of intangible assets in exchange of issuance of common stock | |||||
| Dividend payable to former owner of 42 arising from measurement year adjustment to goodwill | |||||
| Contingent consideration liability recognized with business combination | |||||
| Issuance of common stock pursuant to business combination | |||||
| Common stock to be issued pursuant to business combination | |||||
| Settlement of related party liabilities, Value | |||||
| Issuance of common stock in settlement of liabilities | |||||
| Deferred tax adjustment to goodwill | |||||
Loading...